Hepatitis D MRI: Difference between revisions
m (Changes made per Mahshid's request) |
(Category) |
||
| Line 24: | Line 24: | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Emergency mdicine]] | |||
[[Category:Disease]] | |||
[[Category:Primary care]] | |||
[[Category:Up-To-Date]] | |||
[[Category:Infectious disease]] | |||
[[Category:Hepatology]] | |||
[[Category:Gastroenterology]] | |||
Revision as of 15:52, 21 September 2017
|
Hepatitis D |
|
Diagnosis |
|
Treatment |
|
Hepatitis D MRI On the Web |
|
American Roentgen Ray Society Images of Hepatitis D MRI |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Varun Kumar, M.B.B.S. [2]; João André Alves Silva, M.D. [3] Jolanta Marszalek, M.D. [4]
Overview
The MRI may be used to diagnose/monitor biliary obstruction, cirrhosis, and hepatocellular carcinoma in patients with hepatitis D. MRI findings in these patients may include: nodular appearance of the liver and signs of portal hypertension, such as ascites and splenomegaly.
MRI
In patients with hepatitis D, an MRI may be performed to:[1]
- Exclude biliary obstruction
- Diagnose/monitor hepatic cirrhosis and hepatocellular carcinoma
The MRI findings in patients with hepatic cirrhosis may include: a shrunken liver with nodular appearance, and signs of portal hypertension, such as splenomegaly and ascites.
References
- ↑ Bialecki ES, Di Bisceglie AM (2005). "Diagnosis of hepatocellular carcinoma". HPB (Oxford). 7 (1): 26–34. doi:10.1080/13651820410024049. PMC 2023919. PMID 18333158.